BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11875085)

  • 1. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease.
    Jahnke T; Voshage G; Müller-Hülsbeck S; Grimm J; Heller M; Brossmann J
    J Vasc Interv Radiol; 2002 Mar; 13(3):257-66. PubMed ID: 11875085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial.
    Jahnke T; Andresen R; Müller-Hülsbeck S; Schäfer FK; Voshage G; Heller M; Brossmann J
    J Vasc Interv Radiol; 2003 Jan; 14(1):41-51. PubMed ID: 12525585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result.
    Hu H; Zhang H; He Y; Jin W; Tian L; Chen X; Li M
    Ann Vasc Surg; 2011 Feb; 25(2):210-6. PubMed ID: 21315233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study.
    Kralj I; Boos I; Müller-Bühl U
    Vasa; 2013 Sep; 42(5):340-9. PubMed ID: 23989069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.
    Werner M; Piorkowski M; Thieme M; Nanning T; Beschorner U; Rastan A; Zeller T; Scheinert D
    J Endovasc Ther; 2013 Dec; 20(6):759-66. PubMed ID: 24325691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with a new nitinol self-expanding stent in peripheral arteries.
    Henry M; Amor M; Beyar R; Henry I; Porte JM; Mentre B; Tricoche O; Ethevenot G
    J Endovasc Surg; 1996 Nov; 3(4):369-79. PubMed ID: 8959493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Gißler M; Noory E; Neumann FJ; Zeller T
    Circulation; 2013 Jun; 127(25):2535-41. PubMed ID: 23694965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
    Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
    Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study.
    Wiesinger B; Beregi JP; Oliva VL; Dietrich T; Tepe G; Bosiers M; Hüttl K; Müller-Hülsbeck S; Bray A; Tielemans H; Duda SH
    J Endovasc Ther; 2005 Apr; 12(2):240-6. PubMed ID: 15823072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.
    Schulte KL; Kralj I; Gissler HM; Bagnaschino LA; Buschmann I; Pernès JM; Haage P; Goverde P; Beregi JP; Válka M; Boudny J; Geibel T; Velkoborsky M; Zähringer M; Paetzel C; Fanelli F; Müller-Hülsbeck S; Zeller T; Langhoff R
    J Endovasc Ther; 2012 Dec; 19(6):774-84. PubMed ID: 23210876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
    Teymen B; Akturk S; Akturk U; Tdjani M
    Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
    Donas KP; Schwindt A; Schönefeld T; Tessarek J; Torsello G
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
    Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
    Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
    Kickuth R; Keo HH; Triller J; Ludwig K; Do DD
    J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.